US Patent Issued to Belhaven BioPharma on June 23 for "Dry powder formulations of epinephrine and associated methods" (North Carolina, Wisconsin Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,315, issued on June 23, was assigned to Belhaven BioPharma Inc. (Raleigh, N.C.).

"Dry powder formulations of epinephrine and associated methods" was invented by Scott Lyman (Raleigh, N.C.) and Brian Taubenheim (Elkhart Lake, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions,...